Search Results 1341-1350 of 16224 for monoclonal antibody
A Phase 2 study to investigate the antitumor activity in terms of overall response rate (ORR) of tipifarnib in approximately 20 eligible subjects with CMML.
It is used in patients who are anti-aquaporin-4 (AQP4) antibody positive. This medicine is to be given only by or under the direct supervision of your ...
Antibodies to cell signaling components. Microfluidics services. Assistance with experimental study design to make optimal use of available technology ...
In addition to using stem cells, our researchers are continuing to build on the innovative use of therapeutic antibodies, known as good antibodies, to drive ...
Poor antibody response for COVID vaccine in patients with cancer. Mayo Clinic physicians evaluated the humoral response to the COVID vaccine in patients with ...
gastrointestinal perforation within 6 months of enrollment. - Individuals who previously received topoisomerase I inhibitors or antibody-drug conjugates ...
[antibody to hepatitis B core antigen] antibody test) are eligible. - Patients positive for hepatitis C virus (HCV) antibody are eligible only if polymerase ...
Prior treatment with enfortumab vedotin or other monomethyl auristatin E (MMAE)-based antibody-drug conjugates (ADCs);; Uncontrolled diabetes mellitus. MIBC ...
She says women who later developed breast cancer showed lower amounts of antibody-producing immune cells, known as B cells, in their breast tissue, which ...
Monoclonal B-cell lymphocytosis. Chronic lymphocytic leukemia/small lymphocytic lymphoma. B-cell Non-Hodgkin's lymphoma: Follicular lymphoma;; Mantle cell ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Benefactor support fuels Mayo Clinic’s groundbreaking research. Make a gift today to help us save lives.